HIV-1 infection in rural Africa: Is there a difference in median time to AIDS and survival compared with that in industrialized countries?

AIDS

Volumn 16, Issue 4, 2002, Pages 597-603

  Morgan, Dilys ^a   Mahe, Cedric ^a   Mayanja, Billy ^a   Okongo, J Martin ^a   Lubega, Rosemary ^a   Whitworth, James A G ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

AIDS; HIV 1; Rural Africa; Survival

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AFRICA; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEVELOPED COUNTRY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RURAL POPULATION; SEROCONVERSION; SURVIVAL RATE; UGANDA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; DEVELOPED COUNTRIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RURAL POPULATION; TIME FACTORS; UGANDA;

EID: 0037040349     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200203080-00011     Document Type: Article

References (35)

1. Seroconversion rate, mortality and clinical manifestations associated with the receipt of a human immunodeficiency virus-infected blood transfusion in Kinshasa, Zaire
2. Human immunodeficiency virus infection among employees in an African hospital
3. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection
4. Natural history of human immunodeficiency virus infection in Zaire
5. Reduced rate of disease development after HIV-2 infection as compared to HIV-1
6. Four years of natural history of HIV-1 infection in African women: A prospective cohort study in Kigali (Rwanda), 1988-1993
7. Immunological and clinical stages in HIV-1 infected adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease
8. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection
9. Predictors of mortality among HIV-infected women in Kigali, Rwanda
10. HIV-1 disease progression and AIDS defining disorders in rural Uganda
11. Reductions in risk behaviour provide the most consistent explanation for declining HIV-1 prevalence in Uganda
12. Change in sexual behaviour and decline in HIV infection among young pregnant women in urban Uganda
13. Seven-year trends in HIV-1 infection rates, and changes in sexual behaviour, among adults in rural Uganda
14. HIV-1 incidence and HIV-1-associated mortality in a rural Ugandan population cohort
15. Acquired immune deficiency syndrome (AIDS): Interim proposal for a WHO staging system for HIV-1 infection and disease
16. Survival by AIDS-defining condition in rural Uganda
17. Immunological markers of AIDS progression: Consistency across five HIV-infected cohorts, part 1
18. Longer survival after HIV infection for injecting drug users than for homosexual men: Implications for immunology
19. Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: Results from the ALIVE and ISS studies
20. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly active retroviral therapy: A collaborative re-analysis
21. Determinants of HIV disease progression among homosexual men registered in the tricontinental seroconvertor study
22. The AIDS incubation period in the UK estimated from a national register of HIV seroconvertors
23. Is AIDS a floating pont between HIV seroconversion and death? Insights from the tricontinental seroconvertor study
24. Long-term survival after infection with human immunodeficiency virus type1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995
25. Assessment of the World Health Report 2000
26. Survival differences in patients with AIDS
27. Survival trends for patients with AIDS
28. Zidovudine and the natural history of the acquired immunodeficiency syndrome
29. Survival of adults with AIDS in the United Kingdom
30. Disease progression and survival in HIV-1-infected Africans in London
31. Declines in AIDS incidence and deaths in the USA: A signal change in the epidemic
32. HIV-associated adult mortality in a rural Tanzanian population
33. Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Côte d'Ivoire